Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Drug Security
Drug companies approach brand security issue head on, study shows
September 5th, 2004
A recent U.S. Food and Drug Administration report cited that about 10% of all drugs worldwide are counterfeit. That can mean huge revenue losses, as much as $2 billion annually, for even a mid-sized pharmaceutical company, not to mention the significant damage such fraud inflicts on a company's brand image. Best-in-class pharmaceutical companies employ comprehensive approaches that align such key cross-functional areas as sales, manufacturing and distribution, legal and security in the brand security battle, according to Best Practices, LLC, a pharmaceutical benchmarking and consulting firm. Best Practices, LLC, recently undertook a study through its...
Source: Medical Letter on the CDC & FDA (2004-09-05)
|
